Pharmalytics Corporation is a contract research organization in the Philippines established in 2014. We conduct clinical trials and Bioavailability/Bioequivalence (BA/BE) studies that aim to deliver more affordable and accessible drugs that benefit the Filipino people.

We are a team of well-trained professionals with rich experience in conducting clinical trials and clinical research services for domestic clients and conducting studies in various therapeutic segments and different patient populations. We have immense experience in conducting pharmaceutical studies. Our services are client-focused, flexible, and cost-effective.

We focus on quality and add value to our clients in medical writing services and pharmacovigilance services. We strictly adhere to timely execution of clinical projects and the data we produce is accurate, reliable, comprehensive, and strictly follow the standards of Good Laboratory and Good Clinical Practices.


To conduct bioavailability and bioequivalence studies fully compliant with current standards of Good Laboratory and Good Clinical Practice.

 To provide affordable clinical and analytical services to pharmaceutical manufacturers and distributors.

To partner with the Food and Drugs Administration in ensuring the quality of drugs available in the country.


Pharmalytics Corporation will be the country’s most preferred bioanalytical testing center because of the high quality of clinical study implementation that address the needs of its clientele in a timely manner.

Over the years, Pharmalytics has conducted more than a hundred Bioavailability/Bioequivalence studies sponsored by different drug companies here in the Philippines. With the same goal from these companies, we are one with the Filipino people in helping them afford low-price but high quality and efficacious therapeutic drugs that will lessen their pressing health concerns. We make sure that with every BA/BE study we conduct, our shared understanding on who we are, what we do, how, and why we do it will be our foundation in working compassionately together towards our goal.

Moreover, we have also successfully conducted the following projects: 

  • Phase 1 and Phase 3B Clinical Trials
  • Post Marketing Surveillance (PMS) study
  • Dissolution Testing
  • Migration Testing
  • Pharmacopeial Study
  • PK Determination Studies in Rats
  • Biowaiver Application
  • Data Encoding
  • Glycemic Index Determination Study
  • Discovery and Development of Health Products (DDHP)
  • Determination of B-Hydroxy-B-Methylbutrate
  • Publication and Dessimination of 5 Manuals of the Tuklas Lunas Protocols for Drug Discovery and Development 
  • Standard Protocols for Drug Discovery and Development Research 
  • Medical Writing
error: Content is protected !!
Scroll to Top